NEC is a serious gastrointestinal problem that often affects premature babies.  The condition causes inflammation to the intestinal tissue and can cause a perforation, leading to sepsis and/or death.

Most babies that develop NEC are born premature, or at a low birth weight.  It affects approximately 1 in 1,000 babies.  The risk is greatest for those weighing less than 2 pounds.

The attorneys at Keilty Bonadio are investigating claims relating to the use of Enfamil and Similac in the hospital.  Multiple lawsuits have been filed by parents after their children have developed necrotizing enterocolitis after ingesting Similac or Enfamil formula.  The manufacturers of these products failed to warn of the health risks associated with these products. 

The worst part is these products were specifically marketed for premature infants.

Despite years of research associating cow-based products like Enfamil and Similac with increased risks of developing NEC for premature infants the manufacturers actually promoted these products as safe.

If you or anyone you know has a child has developed NEC, we encourage you to share this information so they can make an informed decision.  At Keilty Bonadio we are investigating claims against Mead Johnson Nutrition Company (Enfamil) and Abbott Laboratories (Similac) for failure to provide parents and medical providers about the risk of side effects of these products that may have contributed to injuries and/or wrongful death.